HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages 855-863

  Bossard, Céline ^a   Bézieau, Stéphane ^b   Matysiak Budnik, Tamara ^c   Volteau, Christelle ^c   Laboisse, Christian L ^b   Jotereau, Francine ^a   Mosnier, Jean François ^b  

^a Team 12   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

colorectal cancer; HLA E; natural killer cells; prognostic biomarker; tumor infiltrating lymphocytes

Indexed keywords

BETA 2 MICROGLOBULIN; CD94 ANTIGEN; HLA E ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2A; TUMOR MARKER;

AGED; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOMA IN SITU; CD8+ T LYMPHOCYTE; CELL DENSITY; CELL INTERACTION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNET RING CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR ESCAPE; TUMOR GROWTH;

AGED; ANTIGENS, CD; BETA 2-MICROGLOBULIN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR ESCAPE; TUMOR MARKERS, BIOLOGICAL;

EID: 84862578622     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26453     Document Type: Article

References (36)

1. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H,. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491-4. (Pubitemid 28376536)
2. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-66. (Pubitemid 41817714)
3. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4. (Pubitemid 44498003)
4. Pagès F, Kirilovsky A, Mlecnik B, Asslaber M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P, Zatloukal K, Trajanoski Z, et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009; 27: 5944-51.
5. Smyth MJ, Godfrey DI, Trapani JA,. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001; 2: 293-9. (Pubitemid 33706339)
6. Halfteck GG, Elboim M, Gur C, Achdout H, Ghadially H, Mandelboim O,. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J Immunol 2009; 182: 2221-30.
7. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V,. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 2009; 119: 1251-63.
8. Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay JY,. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today 1997; 18: 493-7. (Pubitemid 27441593)
9. Steer HJ, Lake RA, Nowak AK, Robinson BW,. Harnessing the immune response to treat cancer. Oncogene 2010; 29: 6301-13.
10. Derré L, Corvaisier M, Charreau B, Moreau A, Godefroy E, Moreau-Aubry A, Jotereau F, Gervois N,. Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 2006; 177: 3100-7. (Pubitemid 44277827)
11. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ,. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-9. (Pubitemid 28099678)
12. Wischhusen J, Friese MA, Mittelbronn M, Meyermann R, Weller M,. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo. J Neuropathol Exp Neurol 2005; 64: 523-8. (Pubitemid 40781155)
13. Levy EM, Bianchini M, Von Euw EM, Barrio MM, Bravo AI, Furman D, Domenichini E, Macagno C, Pinsky V, Zucchini C, Valvassori L, Mordoh J,. Human leukocyte antigen E protein is overexpressed in primary human colorectal cancer. Int J Oncol 2008; 32: 633-41. (Pubitemid 351330470)
14. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lõpez-Botet M, Geraghty DE,. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95: 5199-204. (Pubitemid 28208575)
15. Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE,. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol Res 2006; 35: 263-78.
16. Braud VM, McMichael AJ,. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. Curr Top Microbiol Immunol 1999; 244: 85-95. (Pubitemid 29304672)
17. Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE,. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse. J Immunol 2006; 177: 3590-6. (Pubitemid 44359890)
18. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A,. Surface NK receptors and their ligands on tumor cells. Semin Immunol 2006; 18: 151-8. (Pubitemid 43817561)
19. Greene FL, Sobin LH,. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol 2009; 99: 269-72.
20. Hamilton SR, Bosman FT, Boffetta P, Ilyas M, Morreau H,. Carcinoma of the colon and the rectum. In:, Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO classification of tumours of the digestive system, 4th edn. Lyon: International Agency for Research on Cancer (IARC), 2010. 134-46.
21. Patankar MS, Jing Y, Morrison JC, Belisle JA, Lattanzio FA, Deng Y, Wong NK, Morris HR, Dell A, Clark GF,. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125. Gynecol Oncol 2005; 99: 704-13. (Pubitemid 41686556)
22. Belisle JA, Gubbels JA, Raphael CA, Migneault M, Rancourt C, Connor JP, Patankar MS,. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Immunology 2007; 122: 418-29. (Pubitemid 47556479)
23. Correia MP, Costa AV, Uhrberg M, Cardoso EM, Arosa FA,. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology 2011; 216: 604-12.
24. McNerney ME, Lee KM, Kumar V,. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells. Mol Immunol 2005; 42: 489-94. (Pubitemid 39655959)
25. Raziorrouh B, Schraut W, Gerlach T, Nowack D, Grüner NH, Ulsenheimer A, Zachoval R, Wächtler M, Spannagl M, Haas J, Diepolder HM, Jung MC,. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 2010; 52: 1934-47.
26. Laouar A, Manocha M, Wan M, Yagita H, van Lier RA, Manjunath N,. Cutting Edge: distinct NK receptor profiles are imprinted on CD8 T cells in the mucosa and periphery during the same antigen challenge: role of tissue-specific factors. J Immunol 2007; 178: 652-6. (Pubitemid 46095136)
27. Valés-Gõmez M, Reyburn HT, Erskine RA, Lõpez-Botet M, Strominger JL,. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999; 18: 4250-60. (Pubitemid 29364127)
28. Pietra G, Romagnani C, Mazzarino P, Falco M, Millo E, Moretta A, Moretta L, Mingari MC,. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 2003; 12: 10896-901. (Pubitemid 37140124)
29. Salerno-Gonçalves R, Fernandez-Viña M, Lewinsohn DM, Sztein MB,. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 2004; 173: 5852-62. (Pubitemid 39392176)
30. Speiser DE, Pittet MJ, Valmori D, Dunbar R, Rimoldi D, Liénard D, MacDonald HR, Cerottini JC, Cerundolo V, Romero P,. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 1999; 190: 775-82. (Pubitemid 29451623)
31. Jiang H, Canfield SM, Gallagher MP, Jiang HH, Jiang Y, Zheng Z, HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest 2010; 120: 3641-50.
32. Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM,. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Cancer Res 2005; 65: 2921-9.
33. Pace E, Di Sano C, Ferraro M, Tipa A, Olivieri D, Spatafora M, Santagata R, Bellia V, Gjomarkj M,. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions. Eur J Cancer 2011; 47: 296-304.
34. Guidoboni M, Gafà R, Viel A, Doglioni C, Russo A, Santini A, Del Tin L, Macrì E, Lanza G, Boiocchi M, Dolcetti R,. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001; 159: 297-304. (Pubitemid 33704214)
35. Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K, Kurokawa Y, Satomi S,. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 2004; 91: 1711-7. (Pubitemid 39546145)
36. Gooden M, Lampen M, Jordanova ES, Leffers N, Trimbos JB, van der Burg SH, Nijman H, van Hall T,. HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes. Proc Natl Acad Sci USA 2011; 108: 10656-61.